Dementia is not a specific disease. It’s an umbrella term for a range of symptoms affecting memory, thinking, and daily functioning. Alzheimer’s disease is one specific condition that causes dementia, and it’s the most common one, accounting for 60% to 80% of all dementia cases. Think of it this way: dementia describes what’s happening, while Alzheimer’s explains why it’s happening.
Dementia Is a Syndrome, Not a Disease
A syndrome is a collection of symptoms that tend to show up together. Dementia’s core symptoms include progressive memory loss, difficulty reasoning and problem-solving, trouble with language, and changes in mood or behavior. These symptoms worsen over time and eventually interfere with a person’s ability to manage everyday tasks like paying bills, getting dressed, or navigating familiar places.
Many different diseases can cause dementia. Alzheimer’s is the biggest one, but vascular dementia, Lewy body dementia, and frontotemporal dementia each damage the brain in distinct ways and produce their own patterns of symptoms. Some causes of dementia-like symptoms are even reversible. Thyroid disorders and certain nutritional deficiencies can impair thinking and memory but may improve once the underlying condition is treated.
What Makes Alzheimer’s Different
Alzheimer’s has a specific biological fingerprint. Two types of abnormal protein buildup define the disease: sticky clumps called amyloid plaques that accumulate between brain cells, and tangled fibers of a protein called tau that form inside neurons. These toxic changes can begin a decade or more before any symptoms appear. Over time, they spread through the brain in a predictable pattern, starting in areas involved in memory and gradually reaching regions that control language, reasoning, and sensory processing.
The amyloid buildup is considered the initial trigger. It sets off a chain reaction that leads to tau tangles, which then cause neurons to malfunction and die. As brain tissue shrinks, the symptoms of Alzheimer’s emerge and worsen. This is a fundamentally different process from, say, vascular dementia, where reduced blood flow from strokes or damaged blood vessels starves brain cells of oxygen.
How Symptoms Differ by Type
Because different dementias damage different parts of the brain, the early warning signs vary. Alzheimer’s typically starts with memory problems: forgetting recent conversations, misplacing things, or repeating questions. Some people first notice trouble finding the right word, difficulty judging distances, or impaired reasoning before memory loss becomes obvious.
Vascular dementia tends to affect the speed of thinking and problem-solving first, with memory staying relatively intact early on. Its progression can also look different. Rather than the gradual, steady decline typical of Alzheimer’s, vascular dementia sometimes worsens in noticeable steps, especially when a series of small strokes causes sudden drops in ability.
Lewy body dementia involves abnormal deposits of a protein called alpha-synuclein inside brain cells. These deposits disrupt chemical messengers involved in memory, learning, movement, and mood. People with Lewy body dementia often experience visual hallucinations early on, along with fluctuating alertness and movement problems similar to Parkinson’s disease.
Frontotemporal dementia targets the front and side regions of the brain, so personality changes and language difficulties tend to appear before memory loss. Someone might become uncharacteristically impulsive, apathetic, or socially inappropriate, which can be mistaken for a psychiatric condition rather than a neurological one.
How Alzheimer’s Progresses
Alzheimer’s moves through recognizable stages, though the pace varies from person to person. In the mild stage, which is when most people receive a diagnosis, problems include getting lost in familiar places, trouble managing finances, repeating questions, and personality shifts. Daily life still functions, but cracks are showing.
In the moderate stage, damage spreads to brain areas controlling language, reasoning, and sensory processing. People begin having difficulty recognizing family and friends. They may struggle with multistep tasks like getting dressed. Hallucinations, delusions, paranoia, and impulsive behavior can emerge. This is typically the longest stage.
In severe Alzheimer’s, plaques and tangles have spread throughout the brain and tissue has shrunk significantly. People lose the ability to communicate, become fully dependent on caregivers, and may eventually be bedridden as the body shuts down.
How Doctors Tell Them Apart
Diagnosing the specific type of dementia matters because it affects treatment options and what to expect going forward. When doctors evaluate someone with cognitive decline, they use a combination of cognitive testing, brain imaging, and sometimes lab work to rule out treatable causes like thyroid problems.
For Alzheimer’s specifically, a framework developed by the National Institute on Aging looks for three biological markers: amyloid buildup, tau tangles, and signs of neurodegeneration (brain cell loss). These can be detected through specialized brain scans and spinal fluid tests. A confirmed Alzheimer’s diagnosis now requires both the right symptom pattern and positive results on these biomarker tests. When biomarker testing isn’t available, doctors rely on the clinical picture, particularly whether the symptom pattern matches known Alzheimer’s presentations like progressive memory loss or specific language difficulties.
Treatment Differs by Diagnosis
Because Alzheimer’s has a known biological mechanism, treatments can target it directly. The FDA has approved medications like donanemab (brand name Kisunla) that work by clearing amyloid plaques from the brain. These treatments are designed for people in the early stages, specifically those with mild cognitive impairment or mild dementia, and are given as intravenous infusions. They don’t cure the disease, but they aim to slow its progression by addressing the underlying protein buildup.
Other types of dementia don’t have equivalent disease-targeting treatments. Vascular dementia management focuses on controlling the cardiovascular risk factors (high blood pressure, diabetes, high cholesterol) that cause further blood vessel damage. Lewy body dementia treatment centers on managing specific symptoms like hallucinations and movement problems, with careful attention because some common psychiatric medications can cause severe reactions in these patients.
This is one of the most practical reasons the distinction between dementia and Alzheimer’s matters. A correct diagnosis opens the door to the right treatment approach and helps families plan for what’s ahead.
The Scale of Alzheimer’s Today
An estimated 7.2 million Americans age 65 and older are living with Alzheimer’s dementia in 2025, according to the Alzheimer’s Association. That number is projected to reach 13.8 million by 2060 without major breakthroughs in prevention or treatment. The disease is the dominant driver of dementia worldwide, which is why the two terms are so often used interchangeably, even though doing so obscures the fact that millions of people live with non-Alzheimer’s forms of dementia that require different care and carry different expectations.